复治肺结核患者应用肺泰胶囊的有效性研究

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (34 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the efficacy of application of Feitai Capsules in the retreatment of pulmonary tuberculosis patients.Methods A total of 80 patients of retreated tuberculosis admitted to the Fourth Hospital of Chaoyang City from January 2019 to January 2020 were selected as the research objects.According to the random number table method,the patients were divided into the control group(40 cases)and the experimental group(40 cases).The control group used routine anti-tuberculosis drug treatment,the experimental group adopted the method of adding Feitai Capsules treatment on the basis of conventional anti-tuberculosis drugs.The index of cardiopulmonary function,serum inflammatory factor levels and clinical efficacy were compared between the two groups.Results The levels of oxygen partial pressure,forced expiratory volume in the first second(FEV1),forced vital capacity(FVC),FEV1/FVC after treatment in the experimental group were higher than those in the control group,the levels of carbon dioxide partial pressure,tumor necrosis factor α(TNF-α),interleukin 6(IL-6),interleukin 8(IL-8),and C-reactive protein(CRP)after treatment in the experimental group were lower than those in the control group,the differences were statistically significant(P＜0.05).There were no significant difference in the levels of oxygen partial pressure,FEV1,FVC,FEV1/FVC,carbon dioxide partial pressure,TNF-α,IL-6,IL-8,CRP before treatment in the two groups(P＞0.05).The levels of oxygen partial pressure,FEV1,FVC,FEV1/FVC after treatment in the two groups were higher than those before treatment,the levels of partial pressure of carbon dioxide,TNF-α,IL-6,IL-8,and CRP after treatment in the two groups were lower than those before treatment,the differences were statistically significant(P＜0.05).The total clinical effective rate of the experimental group(90%)was higher than that of the control group(70%),the difference was statistically significant(P＜0.05).Conclusion Feitai Capsules has a significant effect in the treatment of patients with retreatment of pulmonary tuberculosis.Combined use with conventional anti-tuberculosis drugs can effectively improve the cardiopulmonary function and related serum indicators of patients,and it is worthy of clinical application and promotion.

Key words： Retreatment of pulmonary tuberculosis Feitai Capsules Clinical studies Anti-tuberculous therapy

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	JIA Wen-cheng
	LU Guan-nan

Cite this article:

JIA Wen-cheng,LU Guan-nan. Study on the efficacy of application of Feitai Capsules in the retreatment of pulmonary tuberculosis patients[J]. 中国当代医药, 2021, 28(26): 205-208.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I26/205

[1]	郑义彬，杨静秋，肖剑.胸腺五肽联合左氧氟沙星治疗复治菌阳性肺结核的效果及对PCT、hs-CRP 和T 淋巴细胞亚群的影响[J].中外医学研究，2019，17（35）：32-34.
[2]	牛海军.514 例耐多药肺结核患者耐药情况分析[J].河南预防医学杂志，2019，30（12）：933-934.
[3]	齐紊.营养不良对复治结核病患者治疗效果的影响[J].医学食疗与健康，2020，18（14）：43-44.
[4]	徐勇.胸腺五肽联合抗结核药物治疗复治涂阳肺结核的疗效[J].中国继续医学教育，2019，11（33）：133-135.
[5]	夏琴.肺泰胶囊联合利奈唑胺治疗广泛性耐药结核病疗效研究[J].陕西中医，2019，40（4）：469-471.
[6]	孙孟.中西医结合治疗耐多药肺结核患者的护理体会[J].山东医学高等专科学校学报，2018，40（4）：301-303.
[7]	刘锐，张焕.百合固金汤超声电导仪药物透入对复治肺结核患者血清免疫功能及炎症因子水平影响研究[J].辽宁中医药大学学报，2018，20（5）：122-125.
[8]	赵亚婷.黄芪鳖甲汤在治疗糖尿病合并复治肺结核中的作用[J].中医药临床杂志，2018，30（1）：118-121.
[9]	王姬，郑雁，冯马龙.肺泰胶囊联合抗结核治疗方案治疗复治肺结核的临床观察[J].中国中西医结合杂志，2017，37（10）：1196-1200.
[10]	王姬，郑雁，周建芳，冯马龙.初治涂阳肺结核患者肺泰胶囊联合2HRZE/4HR 化疗疗效观察[J].预防医学，2017，29（7）：708-710，713.
[11]	杨春雨.卷曲霉素联合左氧氟沙星对复治涂阳肺结核的有效性及安全性研究[J].中国保健营养，2019，29（10）：133-134.
[12]	程俊伟.含左氧氟沙星化疗方案治疗复治涂阳肺结核的临床效果[J].河南医学研究，2020，29（3）：469-471.
[13]	吴伯华，曹永胜，陈搏智.胸腺肽联合抗结核药治疗复治涂阳肺结核的临床研究[J].现代临床医学，2018，44（1）：58-59.
[14]	赖炎峰，易雪，王诗.肺结核患者治疗出院后应用电话随访的效果分析[J].健康必读，2018（32）：5-6.
[15]	方楚葵，蔡纪平，黎录生.左氧氟沙星联合治疗在复治涂阳肺结核患者中的应用分析[J].现代诊断与治疗，2018，29（5）：732-734.